FDA approves Teva Pharmaceuticals’ CU method July 7, 2022 -- The U.S. Food and Drug Administration (FDA) approved a content uniformity (CU) method from Teva Pharmaceuticals that uses the Agilent TRS100 Raman quantitative pharmaceutical analysis system.Read More
Cell & Gene Meeting on the Mesa 2022 Recap November 9, 2022 -- The Science and Medicine Group team was onsite at this year's Cell & Gene Meeting on the Mesa getting the who, what, and when on the product announcements, science sessions, and deals taking place this year. Find out what we learned in our recap.Read More
Gene therapy targets overactive brain cells in mice, potential neurological treatment November 4, 2022 -- University College London researchers have developed a gene therapy for neurological and psychiatric diseases that reduces the excitability of overactive brain cells. Tested in mice, the scientists contend the treatment could potentially be used in human brain diseases caused by excessive activity of a small number of brain cells.Read More
MIT researchers record cellular memories through protein chains January 4, 2023 -- Using engineered proteins, MIT researchers have designed a system in which they can record “memories” of sequences of cellular events, such as when certain genes are activated, or how cells respond to a drug, as cells turn on series of genes and pathways in performing functions.Read More
Short-lived nasal antibodies against COVID-19 may explain reinfection December 20, 2022 -- Research led by the University of Liverpool and Imperial College London found that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies in the blood last at least a year.Read More
Researchers find new target for drug-resistant ovarian cancer April 17, 2023 -- Researchers working in a preclinical study have verified a new target for recurrent drug-resistant ovarian cancer and provided data to support a treatment approach now in clinical trials. The findings were presented on Sunday, during the American Association for Cancer Research (AACR) 2023 annual meeting.Read More
Cellecta releases NGS assays for T-cell and B-cell receptor chains April 12, 2023 -- Genomics company Cellecta announced on Wednesday that it has launched its DriverMap Adaptive Immune Receptor DNA (AIR-DNA) TCR and BCR kits that provide rapid, single-tube polymerase chain reaction (PCR) analysis of the variability of T-cell and B-cell receptor chains from a range of sample types, including tissue biopsy, whole blood, purified immune cells, and others.Read More